Vulnerabilities

Vulnerability · CVE-2025-8153

Cross-site Scripting vulnerability in NEC Corporation UNIVERGE IX from Ver.9.5 to Ver.10.7, from Ver.10.8.21 to Ver.10.8.36, from Ver.10.9.11 to Ver.10.9.24, from Ver.10.10.21 to V

Published Sep 17, 2025 · catalog updated Sep 17, 2025 · NEC Corporation UNIVERGE IX-R/IX-V

Last checked Oct 29, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-8153. EPSS is 0.33%. Act only if a listed version of NEC Corporation UNIVERGE IX-R/IX-V is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.33%
Remediation
Advisory link
Affected products
vendor NEC Corporation UNIVERGE IX-R/IX-V Ver1.3.16, Ver1.3.21

Cross-site Scripting vulnerability in NEC Corporation UNIVERGE IX from Ver.9.5 to Ver.10.7, from Ver.10.8.21 to Ver.10.8.36, from Ver.10.9.11 to Ver.10.9.24, from Ver.10.10.21 to Ver.10.10.31, Ver.10.11.6 and UNIVERGE IX-R/IX-V Ver1.3.16, Ver1.3.21 allows a attacker to inject an arbitrary scripts may be executed on the user's browser.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor NEC Corporation UNIVERGE IX-R/IX-V Ver1.3.16, Ver1.3.21Ver1.3.16, Ver1.3.21

How to fix CVE-2025-8153

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-8153. EPSS is 0.33%. Act only if a listed version of NEC Corporation UNIVERGE IX-R/IX-V is installed.

Which versions are affected?

Compare what you have installed with NEC Corporation UNIVERGE IX-R/IX-V Ver1.3.16, Ver1.3.21 Ver1.3.16, Ver1.3.21. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.33%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Sep 17, 2025 · EUVD

    Detected

    Cross-site Scripting vulnerability in NEC Corporation UNIVERGE IX from Ver.9.5 to Ver.10.7, from Ver.10.8.21 to Ver.10.8.36, from Ver.10.9.11 to Ver.10.9.24, from Ver.10.10.21 to Ver.10.10.31, Ver.10.11.6 and UNIVERGE IX-R/IX-V Ver1.3.16, Ver1.3.21 allows a attacker to inject an arbitrary scripts may be executed on the user's browser.

  2. Sep 17, 2025 · EUVD

    Updated

    Cross-site Scripting vulnerability in NEC Corporation UNIVERGE IX from Ver.9.5 to Ver.10.7, from Ver.10.8.21 to Ver.10.8.36, from Ver.10.9.11 to Ver.10.9.24, from Ver.10.10.21 to Ver.10.10.31, Ver.10.11.6 and UNIVERGE IX-R/IX-V Ver1.3.16, Ver1.3.21 allows a attacker to inject an arbitrary scripts may be executed on the user's browser.

Sources

  • CVE.orgVulnerability recordCVE-2025-8153

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-8153

    30-day exploitation probability 0.33%

    first.org
  • EUVDVulnerability recordEUVD-2025-29671

    Cross-site Scripting vulnerability in NEC Corporation UNIVERGE IX from Ver.9.5 to Ver.10.7, from Ver.10.8.21 to Ver.10.8.36, from Ver.10.9.11 to Ver.10.9.24, from Ver.10.10.21 to Ver.10.10.31, Ver.10.11.6 and UNIVERGE IX-R/IX-V Ver1.3.16, Ver1.3.21 allows a attacker to inject an

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 29, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSOct 29, 2026
  • CVE.orgOct 23, 2026
  • EUVDOct 23, 2026